---
title: "3 Penny Stocks With Stronger Balance Sheets Worth Watching"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290870422.md"
description: "The article highlights three penny stocks with stronger balance sheets: DroneShield, a defense tech firm shifting to profitability despite governance risks; IperionX, a titanium producer aiming for domestic supply chains but facing funding hurdles; and Sigma Healthcare, a pharmacy group with strong earnings growth but high valuation and margin pressure. These picks are identified via a screener focusing on stocks under $5 with solid financial footing."
datetime: "2026-06-25T19:01:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290870422.md)
  - [en](https://longbridge.com/en/news/290870422.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290870422.md)
generator: "portal-rs"
---

# 3 Penny Stocks With Stronger Balance Sheets Worth Watching

Penny stocks often sound exciting, but the real opportunity can sit in the smaller companies that pair low share prices with healthier balance sheets. With inflation, interest rate decisions and bond yields all in focus, many investors are looking for ways to seek growth potential without taking on extreme early stage risk. That is where the Financially Fit Penny Stocks screener comes in. It highlights stocks trading below 5 that also show signs of stronger financial footing. In this article, you will see three of the best stocks from this screener that may merit a closer look for your watchlist.

## DroneShield (ASX:DRO)

**Overview:** DroneShield is a Sydney based defence technology company that develops and sells counter drone hardware and software, helping militaries, security agencies and critical infrastructure operators detect and disrupt hostile drones across global markets.

**Operations:** DroneShield generates essentially all of its A$216.8 million in revenue from Aerospace & Defense customers, with A$194.9 million from Australia and the rest of the world and A$29.7 million from the USA.

**Market Cap:** A$2.23b

DroneShield operates at the intersection of rapidly growing counter drone demand and a business model that is shifting toward repeat defence procurement, which can be attractive for investors watching this screener. The company has recently moved into profitability with strong earnings growth, while forecasts provided by analysts indicate expectations of robust revenue expansion from its Aerospace & Defense focus and deployments such as the Kansas City FIFA World Cup 2026 security project. At the same time, reliance on external borrowing, an ASIC investigation into past disclosures and a relatively new board and management team underscore governance and funding risks. How those strengths and weak spots balance out is what makes DroneShield a candidate that some investors may wish to study more closely.

DroneShield sits at the crossroads of rising counter drone demand and repeat defence contracts, but the real story sits inside the analyst forecasts for DroneShield and what that might imply for those recent governance questions.

ASX:DRO Earnings & Revenue Growth as at Jun 2026

## IperionX (ASX:IPX)

**Overview:** IperionX is a Charlotte based critical minerals and titanium technology company, working to develop its Titan project in Tennessee while producing titanium metal powders for customers across sectors such as aerospace, defense, energy and medical devices.

**Market Cap:** A$1.30b

IperionX catches the eye because it is trying to build a fully domestic U.S. supply chain for titanium, zircon and heavy rare earths at a time when these materials sit at the center of national security and high tech manufacturing. The Titan project’s Definitive Feasibility Study outlines a large operation with forecast cash flows over a 14 year mine plan. Recent moves such as acquiring adjacent Camden assets and commissioning a 300 ton titanium press indicate plans for a mine to metal platform. At the same time, IperionX remains loss making with a Return on Equity that has declined sharply, a short cash runway and heavy reliance on external borrowing, so the real question is how those plans compare with funding and execution risk.

IperionX is pitching a mine to metal story that could reshape how titanium and rare earths are sourced, yet the real tension sits between those ambitions and its funding and execution hurdles, and the analyst forecasts for IperionX may reveal how that balance is starting to shift

ASX:IPX Earnings & Revenue Growth as at Jun 2026

## Sigma Healthcare (ASX:SIG)

**Overview:** Sigma Healthcare is an Australian pharmacy group that franchises and supplies community pharmacies, runs major brands like Chemist Warehouse, Amcal and Discount Drug Stores, and provides logistics and health services both in store and online.

**Operations:** Sigma Healthcare generates about A$9.55b in revenue, primarily from its Healthcare activities, with A$9.16b from Australia and a smaller A$389.79m contribution from international markets.

**Market Cap:** A$32.21b

Sigma Healthcare may appeal if you want exposure to everyday healthcare spending through a business that combines a large wholesale network with well known retail pharmacy brands. Earnings growth has been strong over 5 years and forecasts still point to growth. However, the current P/E is well above both local and global Healthcare averages while margins have slipped from 11.5% to 6.3%. In addition, there is high funding risk from relying entirely on external borrowing and an inexperienced board and management team. The recent decision to walk away from a Boots deal becomes an important clue to how Sigma is thinking about capital and expansion. The bigger question is how all of that stacks up once you look under the hood.

Sigma Healthcare’s high P/E with thinner margins hints at a story investors have not fully pieced together yet, and the analyst forecasts for Sigma Healthcare could be the clue that changes how you see its next chapter.

ASX:SIG P/E Ratio as at Jun 2026

The three stocks in this article are just a starting point, and the full screener has surfaced 398 more companies with equally compelling financial stories inside the Financially Fit Penny Stocks screener. Use Simply Wall St to identify and analyze the specific catalysts and narratives that matter to you so you can focus on the opportunities that best match your interests across this wider group of financially fit penny stocks.

## Take Control of Your Investment Journey

If IperionX or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market. 

## Seeking Fresh Alternatives Beyond Penny Stocks?

Fresh ideas move first, and markets often reward those who spot quiet momentum before it becomes a breakout story. To avoid waiting until these themes are crowded, investors can consider exploring the following areas now.

-   Target resilient income by focusing on dependable yield payers featured in the 4 dividend fortresses, curated for investors who want payouts that can help balance portfolio swings.
-   Participate in structural demand for essential metals with the curated companies inside the 8 top copper producer stocks, where electrification, infrastructure and supply considerations all meet in one focused list.
-   Identify potential AI-related opportunities by scanning the hand picked companies within the 49 AI infrastructure stocks, designed for investors following the hardware and backbone behind AI development.

 *This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.*

### **New:** Manage All Your Stock Portfolios in One Place

We've created the **ultimate portfolio companion** for stock investors, **and it's free.**

• Connect an unlimited number of Portfolios and see your total in one currency  
• Be alerted to new Warning Signs or Risks via email or mobile  
• Track the Fair Value of your stocks  

Try a Demo Portfolio for Free

### Related Stocks

- [SIG.AU](https://longbridge.com/en/quote/SIG.AU.md)
- [IPX.US](https://longbridge.com/en/quote/IPX.US.md)
- [DRO.AU](https://longbridge.com/en/quote/DRO.AU.md)

## Related News & Research

- [IperionX wins second U.S. Army SBIR task order worth up to US$25.4 million](https://longbridge.com/en/news/297504700.md)
- [DRO: Record revenue growth offset by a significant loss amid heavy investment and operational expansion](https://longbridge.com/en/news/296963670.md)
- [Is Sandfire Resources (ASX:SFR) Above Fair Value After Strong Results And Its Dividend Affirmation?](https://longbridge.com/en/news/297860811.md)
- [Ord Minnett Sticks to Its Hold Rating for Alliance Aviation Services Limited (AQZ)](https://longbridge.com/en/news/297841051.md)
- [BUZZ-Australia's Titomic hits near two-year low on discounted placement](https://longbridge.com/en/news/297723605.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**